2 recruiting, 1 completed, 1 terminated, 1 unknown. 3 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Mucous Membrane Pemphigoid: new trials by email Literature Review of Mucous Membrane Pemphigoid trials Research Report on Mucous Membrane Pemphigoid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Baricitinib for the Treatment of Ocular Mucous Membrane Pemphigoid Baricitinib 2 MG [Olumiant], Methotrexate, Azathioprine - Mucous Membrane Pemphigoid, Cicatrizing Conjunctivitis | Phase 2 | Terminated | Washington University School of Medicine | 2 | 2022-02-21 | 2023-11-07 |
| Dexamethasone Solution and Dexamethasone in Mucolox™ dexamethasone 0.5mg/5ml solution, dexamethasone 0.5mg/5ml solution in Mucolox™ - Oral Lichen Planus, Mucous Membrane Pemphigoid | Phase 2 | Completed | University of California, San Francisco | 29 | 2020-12-26 | 2023-12-15 |
| Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface Tear sample collection via Schirmer strip and subsequent analysis by mass spectrometry - Dry Eye Syndrome, Infectious Keratoconjunctivitis | Recruiting | Centre hospitalier de l'Université de Montréal (CHUM) | 300 | 2020-02-01 | 2026-04-27 | |
| FARD (RaDiCo Cohort) (RaDiCo-FARD) Inherited Epidermolysis Bullosa, Ichthyosis | Recruiting | Institut National de la Santé Et de la Recherche Médicale, France | 900 | 2018-03-07 | 2026-02-12 | |
| Minor Salivary Gland Transplantation for Cicatrizing Conjunctivitis minor salivary gland transplantation - Cicatrizing Conjunctivitis, Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | Not applicable | Unknown | National Taiwan University Hospital | 30 | 2016-09-01 | 2019-02-15 |
| Topical Infliximab in Autoimmune Eyes With Keratoprosthesis topical infliximab - Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis (Lyell) Syndrome | Phase 1 / Phase 2 | Withdrawn | James Chodosh, MD, MPH | 2014-11-01 | 2017-04-07 |
Pemphigoid, Benign Mucous Membrane (6) · Bronchiolitis Obliterans Syndrome (2) · Pemphigus (2) · Stevens-Johnson Syndrome (2) · Albinism (1) · Conjunctivitis, Allergic (1) · Dry Eye Syndromes (1) · Ectodermal Dysplasia (1) · Ichthyosis (1) · Incontinentia Pigmenti (1) · Keratoconjunctivitis, Infectious (1) · Keratoderma, Palmoplantar (1) · Lichen Planus, Oral (1) · Neurofibromatosis 1 (1) · Sjogren's Syndrome (1)
Conjunctival Diseases (6) · Eye Diseases (6) · Skin Diseases (6) · Skin Diseases, Vesiculobullous (6) · Skin and Connective Tissue Diseases (6) · Immune System Diseases (5) · Autoimmune Diseases (3) · Hypersensitivity (3) · Mouth Diseases (3) · Stomatognathic Diseases (3) · Bronchial Diseases (2) · Bronchiolitis (2) · Bronchiolitis Obliterans (2) · Bronchitis (2) · Chemically-Induced Disorders (2)
Azathioprine (1) · Dexamethasone (1) · Infliximab (1) · Methotrexate (1) · Mycophenolic Acid (1) · Solutions (1) · baricitinib (1)
Centre hospitalier de l'Université de Montréal (CHUM) (1) · Institut National de la Santé Et de la Recherche Médicale, France (1) · James Chodosh, MD, MPH (1) · National Taiwan University Hospital (1) · University of California, San Francisco (1) · Washington University School of Medicine (1)
United States (3) · Canada (2) · France (1) · Taiwan (1)
Alessandro Villa, DDS, PhD, MPH (1) · Claes H Dohlman, MD, PhD (1) · Hsiao-Sang Chu, MD, MS (1) · James Chodosh, MD, MPH (1) · Marie-Claude Robert, MD, M.Sc (1) · Mona Harissi-Dagher, MD (1)